# Testing a Medication Risk Communication and Surveillance Strategy: The EMC2 Trial

> **NCT02785458** · NA · COMPLETED · sponsor: **Northwestern University** · enrollment: 1005 (actual)

## Conditions studied

- High-risk Medications

## Interventions

- **BEHAVIORAL:** EMC2 Strategy

## Key facts

- **NCT ID:** NCT02785458
- **Lead sponsor:** Northwestern University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-06-08
- **Primary completion:** 2019-09-20
- **Final completion:** 2019-09-20
- **Target enrollment:** 1005 (ACTUAL)
- **Last updated:** 2021-01-27

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02785458

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02785458, "Testing a Medication Risk Communication and Surveillance Strategy: The EMC2 Trial". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02785458. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*